AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,322 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Follow-Up Questions
What is the price performance of ADDLF stock?
The current price of ADDLF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for AddLife AB?
AddLife AB belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is AddLife AB market cap?
AddLife AB's current market cap is $0
Is AddLife AB a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for AddLife AB, including 1 strong buy, 3 buy, 2 hold, 0 sell, and 1 strong sell
